A
Applied Therapeutics D
D
APLT
0.34850
USD
-0.00
(-0.43%)
مفتوح الان
حجم التداول
8,957
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
49,339,071
الأخبار المقالات
العنوان: Applied Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.